Prosser H M, Wotton D, Gegonne A, Ghysdael J, Wang S, Speck N A, Owen M J
Imperial Cancer Research Fund, London, United Kingdom.
Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9934-8. doi: 10.1073/pnas.89.20.9934.
The activity of the T-cell receptor beta-chain gene enhancer is increased by activators of the protein kinase C pathway during T-cell activation. Analysis of mutant enhancer constructs identified two elements, beta E2 and beta E3, conferring phorbol ester inducibility. Multimerized beta E2 acted in isolation as a phorbol ester-responsive element. Both beta E2 and beta E3, which contain a consensus Ets-binding site, were shown to bind directly to the product of the c-ets-1 protooncogene. Both regions also bound a second factor, core-binding factor. Mutation of the beta E2 Ets site abolished the inducibility of the beta E2 multimer. beta E2 and beta E3 Ets site mutations also profoundly affected activity and inducibility of the enhancer. In contrast, enhancer activity but not its inducibility was affected by mutation of the beta E2 core-binding factor site. Cotransfection studies showed that Ets-1 specifically repressed activity of the multimerized beta E2 element and the complete T-cell receptor beta-chain enhancer. These data show that the T-cell receptor beta-chain enhancer responds to protein kinase C-mediated activation signals via a functional domain, composed of two elements, which contains binding sites for Ets transcription factors and which is negatively regulated by Ets-1.
在T细胞活化过程中,蛋白激酶C途径的激活剂可增强T细胞受体β链基因增强子的活性。对突变增强子构建体的分析鉴定出两个元件,βE2和βE3,它们赋予佛波酯诱导性。多聚化的βE2单独作为佛波酯反应元件起作用。βE2和βE3都含有一个共有Ets结合位点,已证明它们可直接与c-ets-1原癌基因的产物结合。这两个区域还结合了另一种因子,核心结合因子。βE2 Ets位点的突变消除了βE2多聚体的诱导性。βE2和βE3 Ets位点的突变也深刻影响增强子的活性和诱导性。相比之下,βE2核心结合因子位点的突变影响增强子的活性,但不影响其诱导性。共转染研究表明,Ets-1特异性抑制多聚化βE2元件和完整T细胞受体β链增强子的活性。这些数据表明,T细胞受体β链增强子通过一个功能域对蛋白激酶C介导的激活信号作出反应,该功能域由两个元件组成,包含Ets转录因子的结合位点,并受Ets-1负调控。